
oxaliplatin
Pharmaranks rates Oxaliplatin 3.4/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Oxaliplatin is a platinum-based drug used to treat Urinary Bladder Neoplasms, Ovarian Neoplasms, Testicular Neoplasms, Colorectal Neoplasms.
Platinum-Based Drug · by Sandoz
Generic of Eloxatin
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Oxaliplatin
- Drug class
- Platinum-Based Drug
- Form
- Injectable
- Strength
- Oxaliplatin 100MG/VIAL · Oxaliplatin 50MG/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- urinary bladder neoplasms, ovarian neoplasms, testicular neoplasms
- Manufacturer
- Sandoz
- FDA application
- ANDA090849
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
- urinary bladder neoplasms
- ovarian neoplasms
- testicular neoplasms
- colorectal neoplasms
See how Oxaliplatin ranks — best-rated platinum-based drug for:
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Oxaliplatin treat?
- Oxaliplatin (Oxaliplatin) may be used to treat urinary bladder neoplasms, ovarian neoplasms, testicular neoplasms, colorectal neoplasms, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Oxaliplatin rated?
- pharmaranks gives Oxaliplatin a composite score of 3.4 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Oxaliplatin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Oxaliplatin. To pay less, Oxaliplatin is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Oxaliplatin?
- Oxaliplatin is marketed by Sandoz. You can see Sandoz's full profile, rating, and other products on pharmaranks.
- Is Oxaliplatin a brand-name or generic drug?
- Oxaliplatin is a generic medication; its active ingredient is Oxaliplatin. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Oxaliplatin available over the counter?
- No. Oxaliplatin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Oxaliplatin come in?
- Oxaliplatin is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Oxaliplatin?
- Oxaliplatin is classified as platinum-based drug, per the FDA's Established Pharmacologic Class.
- Is Oxaliplatin FDA-registered?
- Oxaliplatin is on record with the U.S. FDA under application number ANDA090849. You can verify this on its official FDA label.
- Has Oxaliplatin been recalled by the FDA?
- Oxaliplatin has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Oxaliplatin safe?
- There's no single safe-or-not verdict. pharmaranks gives Oxaliplatin a recall-safety score of 68/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about Oxaliplatin
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 80,297 reports naming Oxaliplatin, and the FDA flagged 97% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- diarrhoea7,437 reports
- nausea6,038 reports
- vomiting4,904 reports
- neuropathy peripheral4,606 reports
- neutropenia4,544 reports
- thrombocytopenia3,822 reports
- dyspnoea3,553 reports
- pyrexia3,181 reports
Read these as a signal, not a rate. A report does not mean Oxaliplatin caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Oxaliplatin head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
oxaliplatin
68/100